The
chemoattractant protein 1 (MCP-1) is one of the most potent monocyte
chemoattractants whose level is elevated during the course of
AIDS dementia. Earlier studies showed that HIV-1
Tat protein is able to induce transcription of the MCP-1 promoter in astrocytic cells. Furthermore, the TGFbeta-1 signaling pathway through its regulatory
proteins, Smads, modulates Tat activation of MCP-1. Here, we demonstrate that
C/EBPbeta, whose activity is enhanced by a variety of
cytokines during the course of
viral infection, can stimulate basal- and Tat-mediated transcription of MCP-1 in human astrocytic cells. Results using promoter deletion mutants suggested the importance of multiple
C/EBPbeta binding sites scattered within -200 to +1 of the MCP-1 promoter in the observed activity. Results from
DNA binding studies have shown that the interaction of
C/EBPbeta with its DNA motif is diminished by the
C/EBPbeta homologous
protein, CHOP, which possesses the ability to suppress the stimulatory effect of
C/EBPbeta on MCP-1 transcription. Tat, which possesses the ability to interact with
C/EBPbeta, alleviates the negative effect of CHOP and restores
C/EBPbeta interaction with the
DNA. Furthermore, Smad3 and its C-terminal regulatory motif, MH2, interact with
C/EBPbeta and modulate its
DNA binding and transcriptional activity on the MCP-1 promoter. Our results show that the physical and functional interactions of
C/EBPbeta and Tat are severely affected by the presence of Smad3 and MH2. Altogether, these observations identify
C/EBPbeta as a new partner for Tat in stimulating MCP-1 transcription in astrocytes and suggest that the delicate balance among the downstream regulatory
proteins of several
cytokines and
immunomodulators can dictate the level of expression of
chemoattractants, including MCP-1. Hence, inappropriate expression and function of regulatory
proteins such as
C/EBPbeta and Smads by Tat may induce MCP-1 production in astrocytes and contribute to the neuropathogenesis of
AIDS through stimulation of
inflammation in the CNS.